RECRUITING

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

Talk to us

Conditions

Adolescent BehaviorPediatric CancerOncology

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this project is to pilot test an electronically delivered symptom assessment tool Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE), completed by children/adolescents and young adults (AYAs) and caregivers and shared with their clinicians during an outpatient clinic visit, in preparation for a future test of intervention efficacy.

Official Title

Symptom Reporting by Children, Adolescents and Young Adults With Cancer and Their Caregivers During a Clinic Visit: A Feasibility, Usability and Acceptability Study

Quick Facts

Study Start:2024-08-18
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06824441

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:7 Years to 21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. First diagnosis of cancer
  2. 2. Receiving cancer therapy: surgery, myelosuppressive chemotherapy and/or radiation
  3. 3. 7-21 years of age
  4. 4. Completed at least 1 month of cancer chemotherapy treatment and are within 7-28 days of starting a treatment cycle or during ongoing therapy, followed at least every month in clinic
  5. 5. If surgery was part of treatment, the patient must be 3-6 weeks post surgery before participating in study
  6. 6. Caregiver must be present and 18 years and older.
  7. 7. Ability to understand and the willingness to personally sign the written IRB approved informed consent or assent document as appropriate.
  1. 1. Child must be able to read or listen to and understand English and not have cognitive/memory impairments determined by the child's clinician
  2. 2. Caregiver must be able to read and understand English.

Contacts and Locations

Study Contact

Kimberly Pyke-Grimm
CONTACT
650-683-5920
kpgrimm@stanford.edu

Principal Investigator

Kimberly Pyke-Grimm
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

Stanford University
Palo Alto, California, 94304
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Kimberly Pyke-Grimm, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-18
Study Completion Date2025-12

Study Record Updates

Study Start Date2024-08-18
Study Completion Date2025-12

Terms related to this study

Additional Relevant MeSH Terms

  • Adolescent Behavior
  • Pediatric Cancer
  • Oncology